| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 03/27/2008 | US20080075789 Genes differentially expressed in bipolar disorder and/or schizophrenia |
| 03/27/2008 | US20080075788 Medical device that comprises a polymer and an ammonium sulfate salt as part of device, medical device that comprises powder component and a diammonium phosphate salt as part of device, and medical device that comprises an ammonium salt that is part of device; device may be bone cememt, suture, catheter |
| 03/27/2008 | US20080075774 Treatment and/or prevention of a condition major depressive disorder and nicotine addiction; fewer incidences of and/or reduced severity of seizures associated with the administration of bupropion, as compared to known bupropion compositions |
| 03/27/2008 | US20080075762 Compositions for delivery of drug combinations |
| 03/27/2008 | US20080075710 Herbal composition for treating hangovers |
| 03/27/2008 | DE102007022448A1 Cosmetic or dermatological skin treatment agent, useful as skin brightening active agent and for non-therapeutic, cosmetic treatment of the skin, comprises photocatalytically active metal oxide in a carrier |
| 03/27/2008 | CA2660961A1 Novel triclosan salts |
| 03/26/2008 | EP1902718A1 Active foam |
| 03/26/2008 | EP1729786A4 Administration of cisplatin by inhalation |
| 03/26/2008 | EP1567121B1 Nanoparticulate redispersible zinc-oxide powder |
| 03/26/2008 | CN101151039A Inorganic materials for hemostatic modulation and therapeutic wound healing |
| 03/26/2008 | CN101147797A Traditional Chinese medicine for treating chronic gastritis, gastro-duodenal ulcer, not healed aged stomach disease in many years |
| 03/26/2008 | CN101147793A Method for preparing traditional Chinese medicine for treating urinary system diseases |
| 03/26/2008 | CN101147769A Method for preparing traditional Chinese medicine gel preparation for treating cervical erosion and vaginitis |
| 03/26/2008 | CN101147759A Proprietary Chinese medicine for treating leucoderma |
| 03/26/2008 | CN101147758A Medicine for treating stomach disease and replenishing calcium and its preparation method |
| 03/26/2008 | CN101147752A Biologic active element and its preparation technology |
| 03/26/2008 | CN101147730A Constitution of xylitol tablet containing selenium and vitamin E and manufacturing method thereof |
| 03/26/2008 | CN101147587A Calcium-phosphorus mixture and its use |
| 03/26/2008 | CN100376281C A compound preparation for resisting chicken heat stress |
| 03/26/2008 | CN100376276C Soothe tendons and activating-blood anodyne plaster |
| 03/26/2008 | CN100376267C Pharmaceutical formulation consisting of plant extract with calcium coating |
| 03/26/2008 | CN100376252C Use of composition in preparation of medicine and food dual purpose compound vitamin microelement mineral nutritive product for preventing true myopia |
| 03/26/2008 | CN100376237C Use of composition in preparation of nutritive product for preventing pseudomyopia and roal myopia |
| 03/26/2008 | CN100376236C Use of composition in preparation of nutritive product for preventing and treating keratomalacia |
| 03/26/2008 | CN100376235C Use of medicine composition in preparation of nutritive product for preventing and treating synchysis |
| 03/26/2008 | CN100376234C Use of vitamin microelement composition in preparatio of nutritive product for preventing and treating synchysis |
| 03/26/2008 | CN100376233C Use of composition in preparation of product for preventing and treating vision injury syndrome due to TV and computer display light |
| 03/25/2008 | US7348360 Method and composition for delivering zinc to the nasal membrane |
| 03/25/2008 | US7348029 Coating with modified polyoxyethylene glycol in solvent |
| 03/25/2008 | CA2333145C Drug delivery system comprising a homeobox peptide and a non-peptide, non-nucleotide drug |
| 03/25/2008 | CA2162812C Dentifrice compositions containing reactive ingredients stabilized with alkali metal compounds |
| 03/20/2008 | WO2008033069A1 Selective chemokine modulation |
| 03/20/2008 | WO2008032506A1 Mineral water and process for producing the mineral water |
| 03/20/2008 | WO2008032432A1 Gel type enteric nutrient |
| 03/20/2008 | WO2008032054A2 Composite material comprising a tissue matrix compound and a bioactive glass |
| 03/20/2008 | WO2008031619A1 Nano-crystalline earth alkaline fluoride in tooth bleaching agents |
| 03/20/2008 | WO2007124447A3 Use of chalcogenides for treating shock and other adverse conditions |
| 03/20/2008 | WO2007054085A3 Antiviral agent comprising tribomechanically activated zeolite (tmaz), propolis, and colostrum |
| 03/20/2008 | WO2007022734A8 A composition for alleviating a hangover comprising hyaluronic acid and activated carbon |
| 03/20/2008 | US20080071206 Device and method for treatment of dermatomycosis, and in particular onychomycosis |
| 03/20/2008 | US20080070886 Anti-cancer combinations |
| 03/20/2008 | US20080070849 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 03/20/2008 | US20080070848 Anti-cancer combinations |
| 03/20/2008 | US20080070847 Administering 5,6-dimethylxanthenone-4-acetic acid and and administering a compound selected from platinum compounds, vinca alkaloids, alkylating agents, anthracyclines, topoisomerase I inhibitors, antimetabolites and topoisomerase II inhibitors for therapy of cancer |
| 03/20/2008 | US20080069905 Device for application of medicaments, manufacturing method therefor, and method of treatment |
| 03/20/2008 | US20080069904 Inhibition of angiogenesis through nitric oxide tachyphylaxis |
| 03/20/2008 | US20080069903 Electrical producing creams |
| 03/20/2008 | US20080069902 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well |
| 03/20/2008 | US20080069901 Using cisplatin; therapy for bone or liver cancer; oral bioavailable |
| 03/20/2008 | US20080069900 Combination chemotherapy compositions and methods |
| 03/20/2008 | US20080069899 In mixture with drug that prevents Dna reproduction |
| 03/20/2008 | US20080069898 Therapy for skin disorders; acne and antidandruff agent |
| 03/20/2008 | US20080069897 Method for promoting and maintaining respiratory tract health |
| 03/20/2008 | US20080069896 Side effect reduction; reduced toxicity; fine particle size; blend of platinum chloride or chloroplatinic acid with apatite |
| 03/20/2008 | US20080069874 Kits for Prevention and Treatment of Rhinitis |
| 03/20/2008 | US20080069863 Device for treatment of disorders in the oral cavity with nitric oxide, and manufacturing process for the same |
| 03/20/2008 | US20080069855 Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
| 03/20/2008 | US20080069849 Genetic engineered polypeptide; bactericides, viricides, fungicides, parasiticides |
| 03/20/2008 | US20080069848 Device, method, and use for treatment of neuropathy involving nitric oxide |
| 03/20/2008 | CA2663259A1 Selective chemokine modulation |
| 03/20/2008 | CA2661892A1 Gel type enteral nutrient |
| 03/19/2008 | EP1900367A2 Hypoglycemic agent |
| 03/19/2008 | EP1900366A2 Hypoglycemic agent |
| 03/19/2008 | EP1900361A1 Solution for canal irrigation based on sodium hypochlorite and proteolytic enzyme |
| 03/19/2008 | EP1900294A2 Gel-like base preparation for supplementing trace elements and method for its manufacture |
| 03/19/2008 | EP1899314A2 High yield synthesis methods for producing organic salts of strontium |
| 03/19/2008 | EP1898930A2 Treatment of inflammatory conditions |
| 03/19/2008 | EP1898712A2 Fortified cereal bran to promote digestive health |
| 03/19/2008 | EP1898708A2 Compositions and methods for producing a salty taste in foods or beverages |
| 03/19/2008 | EP1429792B1 Strontium compound for treatment of sub-dermal soft tissue pain |
| 03/19/2008 | EP1392271B1 Swallow tablet comprising paracetamol |
| 03/19/2008 | EP1300141B1 Medical composition kit for treating lesioned abnormal tissue |
| 03/19/2008 | EP1246628A4 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 03/19/2008 | CN101146543A Light pharmaceutical water and therapeutic compositions and preparation methods thereof |
| 03/19/2008 | CN101146532A Pharmaceutical compounds |
| 03/19/2008 | CN101146508A Cosmetic and cosmeceutical compositions for restoration of skin barrier function |
| 03/19/2008 | CN101143183A Traditional Chinese medicine for treating intractable headache |
| 03/19/2008 | CN101143176A Traditional Chinese medicine for treating lung cancer |
| 03/19/2008 | CN101143174A Traditional Chinese medicine formula for treating cervical erosion |
| 03/19/2008 | CN101143167A Medicine for treating cancer and preparing method thereof |
| 03/19/2008 | CN101143151A Traditional Chinese medicinal composition for treating cancer |
| 03/19/2008 | CN101143150A External-applied medicine for treating condyloma acuminata |
| 03/19/2008 | CN101143126A Ethyl cellulose slow release system for nucleophilic NO donor medicine and its preparation method |
| 03/19/2008 | CN101142974A Ferrum replenishing jelly and its preparation technology |
| 03/19/2008 | CN101142951A Anti-tumor active nanometer selenium-rich green tea preparation method and its product |
| 03/18/2008 | US7345046 Using quinazoline type compound ; antiproliferative agents |
| 03/18/2008 | US7345029 Osmotic glucose polymer, electrolyte, and buffer solutions administered to patient after heat sterilization |
| 03/18/2008 | US7344735 Method for excystation of sporocysts |
| 03/18/2008 | US7344725 Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions |
| 03/18/2008 | CA2264739C Inhibition of nuclear transcription factor nf-kb by caffeic acid phenethyl ester (cape), derivatives of cape, capsaicin (8-methyl-n-vanillyl-6-nonenamide) and resiniferatoxin |
| 03/18/2008 | CA2106105C Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 03/13/2008 | WO2008030964A2 Use of noncalcium zeolites with added calcium salt in hemostatic devices and products |
| 03/13/2008 | WO2008030947A2 Use of unactivated calcium exchanged zeolites in hemostatic devices and products |
| 03/13/2008 | WO2008029869A1 Agent for prevention or treatment of blood glucose level elevation |
| 03/13/2008 | WO2008029387A1 Multi-layered material |
| 03/13/2008 | WO2008028497A1 A composition of egg white copper complexes with medicinal benifits |
| 03/13/2008 | WO2008001115A3 Pharmaceutical combinations of 1-cyclopropyl-3- [3- (5-m0rphoolin-4-ylmethyl-1h-benzoimidazol-2-yl) -lh-1-pyrazol- 4-yl] -urea |
| 03/13/2008 | WO2007147373A3 Pharmaceutical composition for injectional, particularly targeted local administration |
| 03/13/2008 | WO2007147372A3 Pharmaceutical composition for administration by injection |